Yale Vascular Surgery Symposium: Vascular Care in the Era of COVID-19 Pandemic

Add to Calendar Yale Vascular Surgery Symposium: Vascular Care in the Era of COVID-19 Pandemic 10/1/2021 8:00:00 AM 10/1/2021 2:15:00 PM America/New_York For More Details: https://yale.cloud-cme.com/VascularSurgery2021 Description: Vascular disease is a leading cause of morbidity and mortality and affects more than a third of the adult population. COVID-19 pandemic has significantly impacted patients with vascular disease. Infected patients with COVID-19 are prone to thrombosis and clotting of the arteries and the veins. Patients not infected experience significant delays in needed surgeries at the time of surge because of limited hospital ca... Zoom Webinar false MM/DD/YYYY


Date & Location
Friday, October 1, 2021, 8:00 AM - 2:15 PM, Zoom Webinar

Target Audience
Specialties - Family Practice, Internal Medicine, Surgery, Vascular Medicine
Professions - Nurse, PA, Physician, Student, Surgeon, Technician

Overview

Vascular disease is a leading cause of morbidity and mortality and affects more than a third of the adult population. COVID-19 pandemic has significantly impacted patients with vascular disease. Infected patients with COVID-19 are prone to thrombosis and clotting of the arteries and the veins. Patients not infected experience significant delays in needed surgeries at the time of surge because of limited hospital capacity. The vascular surgeon must have advanced knowledge and experience with the management of vascular problems, including all elements of clinical evaluation, medical management, and indications and techniques relating to open and endovascular treatment of vascular disorders. Other health care providers caring for those patients and sometimes evaluating them before a vascular surgeon do play a major role in the management of this challenging patient population. 

Educating other health care providers about the modern treatment of vascular diseases is paramount to inform the community about the contemporary options for therapy. The impact of the current pandemic on vascular care will be emphasized.

Target Audience: Medical internists, family physicians, surgeons, physician assistants, nurses, technologists, students, and health care providers interested in vascular disease.


Objectives
  1. Discuss advances in medical therapies utilized in the treatment of vascular disease
  2. Describe new directions in the treatment of aneurysmal disease
  3. Review surgical treatments for peripheral arterial disease
  4. Summarize mechanisms of thrombosis and cardiovascular complications in COVID-19 and CT’s response to the pandemic
  5. Discuss anatomic variations and pathologic findings, patient selection, and the use of new endovascular devices in patients with cervical and upper extremity conditions
  6. Identify patients with chronic venous insufficiency who benefit from evaluation by a vascular specialist

Registration

PLEASE NOTE: The first 75 registrants are complimentary. Those thereafter will register using the following fees:

  • Virtual attendance: Physicians - $100
  • Virtual attendance: Nurses/PAs/Allied Health Professionals - $50
  • Virtual attendance: Non-Yale Residents/Fellows/Students† -complimentary
  • Virtual attendance: Yale Residents/Fellows/Students† - complimentary

 

*All cancellations must be received in writing (or via e-mail) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.

†A letter of verification from department head must accompany registration. Letter should be sent separately to Yale CME at the below below. You may also e-mail a pdf copy of your verification letter to [email protected].

Yale CME
c/o Farrah Nettleton
333 Cedar Street
Box 208052
New Haven, CT 06520-8052


Accreditation

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.


Credits
AMA PRA Category 1 Credits™ (5.00 hours), ABIM MOC Part 2 (5.00 hours), ABS CC (4.50 hours), Non-Physician Attendance (5.00 hours)